⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MTVA News
MetaVia Inc. Common Stock
Form 8-K
sec.gov
MTVA
Form 8-K
sec.gov
MTVA
MetaVia Appoints Seasoned Clinical Development Executive Sarah Browne, M.D., as Chief Medical Officer
prnewswire.com
MTVA
Form 8-K
sec.gov
MTVA
MetaVia Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction
prnewswire.com
MTVA
Form 8-K
sec.gov
MTVA
MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update
prnewswire.com
MTVA
Form 8-K
sec.gov
MTVA
MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity
prnewswire.com
MTVA
Form 8-K
sec.gov
MTVA